IMIDomics Establishes a License and Collaboration Partnership with the University of Barcelona to Advance Treatments for IMIDs
SAN RAFAEL, Calif.--(BUSINESS WIRE)--Oct 11, 2023--
Stay updated with breaking news from Imidomics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN RAFAEL, Calif.--(BUSINESS WIRE)--Oct 11, 2023--
Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and IMIDomics, Inc., a patient-centric drug...
SAN RAFAEL, Calif. & BARCELONA--(BUSINESS WIRE)--IMIDomics, Inc., a biotechnology company focused on the discovery and development of new medicines for the treatment of patients with immune-mediated inflammatory diseases (IMIDs), announced today the formation of an Immunology Advisory Board consisting of a number of...
IMIDomics, Inc., a privately held global biotechnology company focused on the discovery and development of new targets and medicines for the treatment of patients with immune-mediated inflammatory diseases